Jean De Dieu Habimana

19 Yuquan Road
Shijingshan, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Network Pharmacology-based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment.

Network Pharmacology-based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment.

Journal: Current cancer drug targets

Published: April 17, 2024

Potential Target of CDK6 Signaling Pathway for Cancer Treatment.

Potential Target of CDK6 Signaling Pathway for Cancer Treatment.

Journal: Current drug targets

Published: March 04, 2024

NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route.

NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route.

Journal: Cancer cell international

Published: December 01, 2023

HIF-1α promotes kidney organoid vascularization and applications in disease modeling.

HIF-1α promotes kidney organoid vascularization and applications in disease modeling.

Journal: Stem cell research & therapy

Published: July 18, 2023

SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.

SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: April 04, 2023

Correction: Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.

Correction: Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.

Journal: Cell death & disease

Published: July 28, 2022

MicroRNA-206 down-regulated human umbilical cord mesenchymal stem cells alleviate cognitive decline in D-galactose-induced aging mice.

MicroRNA-206 down-regulated human umbilical cord mesenchymal stem cells alleviate cognitive decline in D-galactose-induced aging mice.

Journal: Cell death discovery

Published: February 14, 2022

Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.

Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.

Journal: Cell death & disease

Published: January 12, 2022

Rational Programming of Cas12a for Early-Stage Detection of COVID-19 by Lateral Flow Assay and Portable Real-Time Fluorescence Readout Facilities.

Rational Programming of Cas12a for Early-Stage Detection of COVID-19 by Lateral Flow Assay and Portable Real-Time Fluorescence Readout Facilities.

Journal: Biosensors

Published: October 05, 2021

A rapid and sensitive CRISPR/Cas12a based lateral flow biosensor for the detection of Epstein-Barr virus.

A rapid and sensitive CRISPR/Cas12a based lateral flow biosensor for the detection of Epstein-Barr virus.

Journal: The Analyst

Published: September 28, 2020

Generation of UCiPSC-derived neurospheres for cell therapy and its application.

Generation of UCiPSC-derived neurospheres for cell therapy and its application.

Journal: Stem cell research & therapy

Published: July 23, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026